Prediction of tumor deposits in stage I-III gastric cancer: a clinically applicable nomogram integrating clinicopathology outcomes
This TD-specific nomogram, incorporating tumor size, serum biomarkers (CEA/CA199), and pathological staging (pN), provides a clinically applicable tool for preoperative risk stratification and personalized therapeutic decision-making in stage I-III gastric cancer.
Authors
- Song Guo (ORCID: https://orcid.org/0000-0002-1345-9860)
- Kunjie Wang (ORCID: https://orcid.org/0000-0001-8289-2791)
- Weiguang Yu (ORCID: https://orcid.org/0000-0003-4687-2624)
- Shenyong Su (ORCID: https://orcid.org/0000-0001-7985-8998)
- Lin An
- Yuanfang Zhang (ORCID: https://orcid.org/0000-0002-0293-7513)
- Na Xiao (ORCID: https://orcid.org/0000-0003-3129-2467)
- Yue Huo
Institutions
- Sun Yat-sen University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Affiliated Hospital of Hebei University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-05-30
- DOI
- https://doi.org/10.3389/fmed.2025.1577569
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.52